We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVV icon
76
Ovintiv
OVV
$17.5B
$116M 0.26%
2,296,479
-1,782,016
-44% -$93.1M
WMT icon
77
Walmart Inc
WMT
$871B
$116M 0.26%
2,450,925
-704,970
-22% -$33.5M
MRK icon
78
Merck
MRK
$324B
$115M 0.26%
1,033,806
+372,519
+56% +$38.1M
MCO icon
79
Moody's
MCO
$81.7B
$114M 0.26%
410,020
+245,847
+150% +$67.2M
PGR icon
80
Progressive
PGR
$124B
$111M 0.25%
858,728
+287,027
+50% +$36.4M
CSGP icon
81
CoStar Group
CSGP
$11.3B
$111M 0.25%
1,440,176
+311,658
+28% +$24.4M
QGEN icon
82
Qiagen
QGEN
$8.53B
$111M 0.25%
2,087,493
-130,232
-6% -$6.42M
DXCM icon
83
DexCom
DXCM
$27.6B
$111M 0.25%
979,856
+938,909
+2,293% +$103M
NFLX icon
84
Netflix
NFLX
$292B
$110M 0.25%
3,726,970
-2,222,680
-37% -$62.3M
SO icon
85
Southern Company
SO
$110B
$108M 0.24%
1,518,590
+635,046
+72% +$42.5M
DB icon
86
Deutsche Bank
DB
$66.3B
$108M 0.24%
9,569,090
+3,269,792
+52% +$32.3M
ETSY icon
87
Etsy
ETSY
$7.65B
$106M 0.24%
886,097
+808,650
+1,044% +$92.5M
KR icon
88
Kroger
KR
$34.8B
$106M 0.24%
2,378,830
-3,652,752
-61% -$168M
MU icon
89
Micron Technology
MU
$1.04T
$104M 0.23%
2,086,285
+1,332,423
+177% +$72.9M
UBS icon
90
UBS Group
UBS
$170B
$103M 0.23%
5,522,361
+5,286,562
+2,242% +$89.9M
MELI icon
91
Mercado Libre
MELI
$91.3B
$101M 0.23%
119,860
+82,640
+222% +$73.6M
VICI icon
92
VICI Properties
VICI
$29.4B
$97.2M 0.22%
+2,999,723
New +$96.4M
VRSK icon
93
Verisk Analytics
VRSK
$26.4B
$96.3M 0.22%
546,022
+129,922
+31% +$22.8M
CHWY icon
94
Chewy
CHWY
$8.54B
$96M 0.22%
2,587,868
+692,631
+37% +$27M
META icon
95
Meta Platforms (Facebook)
META
$1.51T
$94.9M 0.21%
788,777
-139,126
-15% -$16.3M
KO icon
96
Coca-Cola
KO
$354B
$93.8M 0.21%
1,475,041
+409,533
+38% +$24.7M
XENE icon
97
Xenon Pharmaceuticals
XENE
$6.32B
$93.3M 0.21%
2,366,178
-444,917
-16% -$16.2M
TECH icon
98
Bio-Techne
TECH
$11.2B
$91.9M 0.21%
1,108,443
-1,217,309
-52% -$96.7M
AVGO icon
99
Broadcom
AVGO
$1.82T
$90.3M 0.2%
1,615,900
-2,680,050
-62% -$134M
TXN icon
100
Texas Instruments
TXN
$255B
$89.2M 0.2%
539,962
-177,548
-25% -$29.6M
2 3
4
5 6

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.